This trial is conducted in the United States of America (USA). The aim of this trial is to
examine whether nurses prefer to use the NovoFine® Autocover Needle or the BD Safety Glide
(TM) Syringe (only) in a hospital setting. The number of needle stick injuries will also be
evaluated and whether these hospital nurses prefer the safety features of the NovoFine®
Autocover Needle versus those of the BD Safety Glide (TM) Syringe. The identified hospital
nurses will evaluate the two types of needles during standard administration of insulin to
patients being treated for diabetes.
- Hospital nurses with prior injection training without an infectious blood borne